Date | Time | Source | Headline | Symbol | Company |
11/02/2009 | 3:20PM | Dow Jones News | FDA Approves New Byetta Label Amid Renal-Failure Reports | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/02/2009 | 6:07AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/01/2009 | 6:30PM | PR Newswire (US) | Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity | NASDAQ:AMLN | |
10/30/2009 | 8:16PM | PR Newswire (US) | BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes | NASDAQ:AMLN | |
10/29/2009 | 8:34AM | Dow Jones News | UPDATE: Roche's New Diabetes Drug Works Better Than Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
10/29/2009 | 5:02AM | Dow Jones News | Roche: New Diabetes Drug Works Better Than Byetta - Study | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
10/27/2009 | 6:50AM | Marketwired | MWW, VRTX, BRCD, TIBX, AMLN and BMRN Free Research report on BenchmarkJournal.com | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/22/2009 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference | NASDAQ:AMLN | |
10/20/2009 | 4:10PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/20/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/19/2009 | 5:21PM | Dow Jones News | 2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron Consulting | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
10/19/2009 | 4:17PM | Dow Jones News | UPDATE: Galleon Holdings Include OSI Pharma, Huron Consulting | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
10/19/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/19/2009 | 4:05PM | Dow Jones News | Galleon Holdings Include OSI Pharmaceuticals, Huron Consulting | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
10/16/2009 | 7:18AM | Marketwired | AnalystChoice.com Provides Analytical Coverage on COMS, AMLN, ERIC, CPST, ESLR and CVBF | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/13/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/09/2009 | 5:31PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/07/2009 | 6:32AM | Marketwired | RothmanResearch.com Stock Review for ETFC, COMS, AMLN, ESLR, BMRN and ISIL | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2009 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2009 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2009 | 6:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/06/2009 | 6:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/30/2009 | 6:16AM | Dow Jones News | Novo Nordisk's Diabetes Drug Victoza Successful In Study | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
09/24/2009 | 8:05AM | Business Wire | Alkermes Announces Amylin and Lilly Will Present More than 20 Studies for Exenatide at EASD 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/24/2009 | 8:00AM | PR Newswire (US) | Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/24/2009 | 6:02AM | Marketwired | WallStSense.com Fundamental & Technical Coverage of DRYS, COMS, ETFC, AMLN, ISIL and ARUN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/18/2009 | 4:27PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
09/18/2009 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |